AU529307B2 - Benzodiazepin adjuvants - Google Patents

Benzodiazepin adjuvants

Info

Publication number
AU529307B2
AU529307B2 AU76517/81A AU7651781A AU529307B2 AU 529307 B2 AU529307 B2 AU 529307B2 AU 76517/81 A AU76517/81 A AU 76517/81A AU 7651781 A AU7651781 A AU 7651781A AU 529307 B2 AU529307 B2 AU 529307B2
Authority
AU
Australia
Prior art keywords
benzodiazepin
adjuvants
benzodiazepin adjuvants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU76517/81A
Other languages
English (en)
Other versions
AU7651781A (en
Inventor
Billie Kenneth Koe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of AU7651781A publication Critical patent/AU7651781A/en
Application granted granted Critical
Publication of AU529307B2 publication Critical patent/AU529307B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU76517/81A 1980-10-17 1981-10-16 Benzodiazepin adjuvants Ceased AU529307B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/197,872 US4320124A (en) 1980-10-17 1980-10-17 Composition for enhancing binding of a benzodiazepine to central benzodiazepine receptors and use thereof
US197872 1980-10-17

Publications (2)

Publication Number Publication Date
AU7651781A AU7651781A (en) 1982-04-22
AU529307B2 true AU529307B2 (en) 1983-06-02

Family

ID=22731077

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76517/81A Ceased AU529307B2 (en) 1980-10-17 1981-10-16 Benzodiazepin adjuvants

Country Status (10)

Country Link
US (1) US4320124A (en:Method)
EP (1) EP0050487B1 (en:Method)
JP (1) JPS5795912A (en:Method)
KR (1) KR830007074A (en:Method)
AU (1) AU529307B2 (en:Method)
DE (1) DE3166349D1 (en:Method)
GR (1) GR75097B (en:Method)
IL (1) IL64062A0 (en:Method)
NZ (1) NZ198657A (en:Method)
PT (1) PT73746B (en:Method)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406888A (en) * 1981-01-09 1983-09-27 Pfizer Inc. Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution
US6031098A (en) * 1997-08-11 2000-02-29 California Institute Of Technology Detection and treatment of duplex polynucleotide damage
US6617321B2 (en) * 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
US20030199496A1 (en) * 2002-04-22 2003-10-23 Simon David Lew Pharmaceutical compositions containing alpha3beta4 nicotinic receptor antagonists and methods of their use
US20090156565A1 (en) * 2004-12-03 2009-06-18 The Children's Hospital Of Philadelphia Composition and use thereof in enhancing a therapeutic effect of an antiepileptic drug
US7932249B2 (en) * 2005-01-05 2011-04-26 Eli Lilly And Company Olanzapine pamoate dihydrate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862986A (en) * 1966-07-01 1975-01-28 Hoffmann La Roche 1-Hydroxymethyl-amino-2-alkyl-or allyl-2-(3{40 -methoxy-phenyl)-chclohexanes
ZA772899B (en) * 1976-05-17 1978-04-26 Pfizer 9-hydroxyhexahydrobenzol(c)quinolines and intermediates therefor
US4206225A (en) * 1978-09-22 1980-06-03 Pfizer Inc. 2,10-Disubstituted dibenzo[b,d]pyrans and benzo[c]quinolines
US4228169A (en) * 1979-06-26 1980-10-14 Pfizer Inc. 1,9-Dihydroxyoctahydrobenzo[c]quinolines and 1-hydroxyhexahydrobenzo[c]quinoline-9(8H)-ones as antiemetic agents

Also Published As

Publication number Publication date
PT73746A (en) 1981-10-01
GR75097B (en:Method) 1984-07-13
JPS5795912A (en) 1982-06-15
KR830007074A (ko) 1983-10-14
PT73746B (en) 1983-11-08
NZ198657A (en) 1985-05-31
EP0050487A1 (en) 1982-04-28
IL64062A0 (en) 1982-01-31
US4320124A (en) 1982-03-16
EP0050487B1 (en) 1984-09-26
AU7651781A (en) 1982-04-22
DE3166349D1 (en) 1984-10-31

Similar Documents

Publication Publication Date Title
AU544099B2 (en) Triazolylpentenols
AU537992B2 (en) Polusilanes
AU6594981A (en) Platinum-diamines
AU541995B2 (en) m
AU538782B2 (en) Triazoloquinoxalin-4-ones
AU536754B2 (en) Imidodisulfamides
AU548992B2 (en) 2-guanidno-4-heteroarylthiazoles
AU6591180A (en) Indoxylmaltodextrins
AU7395881A (en) Cloches
AU527275B2 (en) Auto-diaphragm hemodialyser
AU7139981A (en) N6-carboxylalkyladenosines
AU7363881A (en) Glycosylglucans
AU529307B2 (en) Benzodiazepin adjuvants
AU539565B2 (en) If amilifier
AU534814B2 (en) Showstand
AU537073B2 (en) Haloacetanilide
AU6918081A (en) Pyrrolylpiperidines
AU541732B2 (en) 11a-amino-androstanes
AU517843B2 (en) Guanylamidines
AU7011481A (en) Phthalimidoguanidines
AU7850181A (en) 4-cyclopropylmethoxypyrimidines
AU545894B2 (en) Pyrazolobenzazepines
AU555772B2 (en) Cribwalling
AU7722381A (en) Chair
AU7801281A (en) Fingermodell